Medicare Enrolled
Dr. Vijay Haryani, MD
Cardiovascular Disease · Vero Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haryani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haryani? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haryani
Dr. Vijay Haryani is a cardiovascular disease in Vero Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Haryani performed 4,550 Medicare services across 2,958 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haryani received a total of $457,589 from 58 pharmaceutical and/or device companies across 1345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haryani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 24% volume in FL$ $457,589 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,550
Medicare services
Top 24% in FL for cardiovascular disease
2,958
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~239 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,333 | $88 | $198 |
| Electrocardiogram (EKG), 12-lead | 516 | $10 | $88 |
| Hospital follow-up visit, moderate complexity | 301 | $63 | $134 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 230 | $4 | $64 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 189 | $51 | $280 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 178 | $18 | $75 |
| Hospital follow-up visit, high complexity | 174 | $94 | $194 |
| Echocardiogram, transthoracic | 144 | $45 | $460 |
| Office visit, established patient (20-29 min) | 120 | $63 | $135 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 114 | $10 | $91 |
| Remote pacemaker/defibrillator monitoring, 90 days | 112 | $16 | $73 |
| Remote pacemaker monitoring, 90 days | 102 | $22 | $75 |
| Initial hospital admission, high complexity | 100 | $134 | $378 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 92 | $55 | $796 |
| EKG interpretation and report | 85 | $5 | $47 |
| Ultrasound of heart, follow-up | 57 | $19 | $176 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 55 | $13 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 51 | $2 | $115 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 44 | $19 | $114 |
| Ultrasound of heart with probe in esophagus, with report | 44 | $84 | $241 |
| Injection of x-ray contrast during ultrasound of heart | 44 | $24 | $75 |
| Ultrasound of heart blood flow, valves and chambers | 42 | $14 | $216 |
| Ultrasound of both sides of head and neck blood flow | 38 | $31 | $83 |
| Ultrasound study of arm and leg arteries | 38 | $10 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 36 | $16 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 36 | $10 | $60 |
| Cardiac catheterization | 36 | $196 | $2,798 |
| Initial hospital admission, moderate complexity | 33 | $99 | $257 |
| New patient office visit (45-59 min) | 27 | $113 | $306 |
| Review by radiologist of both arms or legs arteries image | 26 | $74 | $420 |
| Ultrasound of leg arteries or artery grafts | 26 | $30 | $81 |
| Coronary stent placement | 20 | $434 | $1,302 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $76 | $282 |
| Office visit, established patient, complex (40-54 min) | 17 | $124 | $267 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $6 | $75 |
| Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report | 13 | $13 | $47 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $287 | $2,700 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $19 | $55 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $58 | $290 |
| Ultrasound of leg arteries at rest and after exercise | 11 | $19 | $53 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.5% high complexity
9.9% medium
78.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$457,589
Total received (2018-2024)
Avg $65,370/year across 7 years
Top 1% in FL for cardiovascular disease
58
Companies
1,345
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$438,040 (95.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,549 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$38,599
2023$36,002
2022$195,451
2021$55,131
2020$28,308
2019$57,062
2018$47,036
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$117,006
Novo Nordisk Inc
$102,563
Boehringer Ingelheim Pharmaceuticals, Inc.
$67,961
AstraZeneca Pharmaceuticals LP
$36,683
United Therapeutics Corporation
$24,207
Bayer HealthCare Pharmaceuticals Inc.
$22,547
E.R. Squibb & Sons, L.L.C.
$18,133
Lilly USA, LLC
$16,792
PFIZER INC.
$13,045
Merck Sharp & Dohme LLC
$12,129
Novartis Pharmaceuticals Corporation
$10,757
Abbott Laboratories
$4,461
Penumbra, Inc.
$1,534
Medtronic, Inc.
$1,116
Amgen Inc.
$1,065
Inari Medical, Inc.
$836
Actelion Pharmaceuticals US, Inc.
$696
Philips Electronics North America Corporation
$688
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$631
Alnylam Pharmaceuticals Inc.
$586
Endologix, Inc.
$440
Esperion Therapeutics, Inc.
$376
Regeneron Healthcare Solutions, Inc.
$236
Bayer Healthcare Pharmaceuticals Inc.
$229
Medtronic Vascular, Inc.
$225
ABIOMED
$213
Gilead Sciences, Inc.
$208
Boston Scientific Corporation
$199
SANOFI-AVENTIS U.S. LLC
$191
Impulse Dynamics (USA) Inc.
$177
Bard Peripheral Vascular, Inc.
$142
Vifor Pharma, Inc.
$135
GlaxoSmithKline, LLC.
$125
Amarin Pharma Inc.
$121
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$120
SCPHARMACEUTICALS INC.
$110
Kowa Pharmaceuticals America, Inc.
$88
Lundbeck LLC
$86
Cook Medical LLC
$85
Kiniksa Pharmaceuticals International, plc
$82
Terumo Medical Corporation
$81
Chiesi USA, Inc.
$77
Lexicon Pharmaceuticals, Inc.
$71
Relypsa, Inc.
$56
Nuwellis, Inc.
$26
Veryan Medical Incorporated
$25
CVRx, Inc.
$24
Kiniksa Pharmaceuticals, Ltd.
$24
BIOTRONIK INC.
$23
Allergan Inc.
$23
Shockwave Medical, Inc
$21
InfoBionic, Inc
$19
BOSTON SCIENTIFIC CORPORATION
$18
Daiichi Sankyo Inc.
$17
CSL Behring
$17
Merck Sharp & Dohme Corporation
$16
CHIESI USA, INC.
$14
CARDIVA MEDICAL, INC.
$14
Top 3 companies account for 62.8% of total payments
Associated products mentioned in payments ›
(6342) Intrasight Integ · (6571) Eagle Eye · (6577) Visions 014 · AMPLATZER Occluders · AMVUTTRA · AREXVY · Adempas · AngioSeal · Aquadex Smartflow Console · Arcalyst · Atlas · Azure · BRILINTA · BYSTOLIC · Barostim Neo System · BioMimics 3D Vascular Stent System · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · CLEVIPREX 25MG/50ML · COMET · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · ClosureFast · Cook Medical AAA · Cook Medical Thoracic · CoreValve Evolut · Corlanor · DIAMONDBACK PERIPHERAL · ELIQUIS · ELUVIA · ENTRESTO · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · Glidesheath · HAWKONE · HawkOne · HeartMate 3 Left Ventricular Dev · IGT D Peripheral · INJECTAFER · IVUS Systems · Impella · Indigo System · Inpefa · JARDIANCE · JETI · KENGREAL · Kcentra · Kerendia · LAUNCHER · LEQVIO · LOKELMA · LifeStream · LifeVest · Livalo · MAMBA · MetaCross · Micra · MoMe Kardia · NEXLETOL · NEXLIZET · NONE · NORTHERA · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Occluders · Ovation · Ozempic · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · RESOLUTE ONYX · RYBELSUS · Repatha · Resolute · Reveal LINQ · Rybelsus · S · SYMPLICITY G3 · SYNERGY · Saxenda · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRULANCE · TYVASO · Telescope · Tresiba · Trilogy 100 · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · Vascular Closure Device · Vascular Lithotripsy · Veltassa · Venovo · Verquvo · Verrata · WAINUA · WATCHMAN Access System · Wegovy · Wolverine Coronary Cutting Balloon · XARELTO · ZENITH SPIRAL-Z
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in FL.
Equivalent to $10,057 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
43
Per 100K population
26.2
County median income
$71,049
Nearest hospital
CLEVELAND CLINIC INDIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Haryani is a clinical cardiology specialist, with above-average Medicare volume (top 24% in FL), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Haryani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Haryani performed 1,333 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haryani receive payments from pharmaceutical companies?
Yes. Dr. Haryani received a total of $457,589 from 58 companies across 1,345 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haryani's costs compare to other cardiovascular diseases in Vero Beach?
Dr. Haryani's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haryani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Vero Beach
Browse cardiovascular diseases in Vero Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology